Novo Nordisk, the maker of weight loss drug Wegovy, will lay off about 9,000 people as it grapples with rising competition in ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Novo Nordisk, the maker of blockbuster weight-loss drug Wegovy, said on Wednesday it will cut 9,000 jobs in a bid to reignite ...

Novo Nordisk cited a "more competitive and consumer-driven" market while announcing the elimination of 9,000 roles.

PGIM shares how the Jennison Health Sciences Fund weathered Q2 volatility by leaning into undervalued innovators. Discover ...

Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative ...

Tribeca Studios has launched a new incubator program, which aims to empower rising filmmakers to more earnestly portray diseases and health-related stories on-screen. Tribeca created the program in ...

The restructuring, which would eliminate 11% of the company's workforce, aimed to reduce organizational complexity and speed ...

Lilly, which sells the Alzheimer’s drug Kisunla, has recruited Moore to its global “Brain Health Matters” campaign. Drawing ...

The pharmaceutical giant will axe over 11% of its global workforce as rival Eli Lilly gathers market share in the obesity ...